Biotech Rose with the Virus. Now It’s Falling Behind

by | Mar 19, 2021 | BioTech Stocks, Outside Takes, Tech Stocks

This is originally from post published on on ETFTrends.com.

The S&P 500 Biotech index rose as much as 25% last year after falling as low as 8% during the apex of last year’s sell-offs. Now, downward pressure is helping leveraged inverse funds like the Direxion Daily S&P Biotech Bear 3X Shares (LABD). “Lossmaking pharmaceutical and biotech companies dominate the list of US stocks most […]

The post Biotech Rose with the Virus. Now It’s Falling Behind appeared first on ETF Trends.


This is originally from post published on on ETFTrends.com.

>

Pin It on Pinterest

Share This